Coverage
-
June 11, 2013
A California judge on Monday ordered NuVasive Inc. to pay royalty rates between 3 and 6 percent higher than stipulated in a $101 million jury verdict for its post-verdict infringement of patents related to implants and devices used in spinal surgeries.
4 other articles on this case.
View all »